Research highlights
From 2006-2011, the Consortium for Functional Glycomics (CFG) and the Nature Publishing Group (NPG) collaborated to provide the Functional Glycomics Update, a one-stop resource with monthly updates on the latest developments in glycobiology. Here, access the complete archive of Research Highlights, short accessible pieces that put into context must-read papers related to Functional Glycomics. Original pieces created by NPG as part of the NPG-CFG partnership are subject to copyright by the Nature Publishing Group, a division of Macmillan Publishers Limited; used with permission.
July 2008
Tumor vaccination: C-lectin a new receptor
CD8
+ dendritic cells are characterized by a novel C-lectin receptor termed DNGR-1, which is a promising candidate for tumor vaccination because of its endocytic behavior.Functional Glycomics Gateway (2008)
doi:10.1038/fg.2008.32Muscular dystrophy: Dystroglycan's unique features
An 18-meric
-dystroglycan sequence has been proposed as the preferred sequence for O-mannosylation, and new research shows that sequences upstream of O-mannosylation sites may also guide the mannosyltransferase complex.Functional Glycomics Gateway (2008)
doi:10.1038/fg.2008.33Tumor glycosylation: Sialic acid self-protection
Cancer cells may protect themselves against apoptosis by secreted galectin-3 by a concomitant increase in
2,6-sialylation.Functional Glycomics Gateway (2008)
doi:10.1038/fg.2008.34
